BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8182230)

  • 1. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid.
    Cugno M; Cicardi M; Agostoni A
    J Allergy Clin Immunol; 1994 May; 93(5):870-6. PubMed ID: 8182230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune C1 inhibitor deficiency: report of eight patients.
    Cicardi M; Bisiani G; Cugno M; Späth P; Agostoni A
    Am J Med; 1993 Aug; 95(2):169-75. PubMed ID: 8356982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of plasmin during acute attacks of hereditary angioedema.
    Cugno M; Hack CE; de Boer JP; Eerenberg AJ; Agostoni A; Cicardi M
    J Lab Clin Med; 1993 Jan; 121(1):38-43. PubMed ID: 8426080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune C1 inhibitor deficiency and angioedema.
    Valsecchi R; Reseghetti A; Pansera B; Di Landro A
    Dermatology; 1997; 195(2):169-72. PubMed ID: 9310729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenetic and clinical aspects of C1 inhibitor deficiency.
    Cicardi M; Bergamaschini L; Cugno M; Beretta A; Zingale LC; Colombo M; Agostoni A
    Immunobiology; 1998 Aug; 199(2):366-76. PubMed ID: 9777420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
    Alsenz J; Loos M
    Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies.
    Cugno M; Cicardi M; Coppola R; Agostoni A
    Immunopharmacology; 1996 Jun; 33(1-3):361-4. PubMed ID: 8856187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the coagulation cascade in C1-inhibitor deficiencies.
    Cugno M; Cicardi M; Bottasso B; Coppola R; Paonessa R; Mannucci PM; Agostoni A
    Blood; 1997 May; 89(9):3213-8. PubMed ID: 9129025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.
    Cugno M; Zanichelli A; Bellatorre AG; Griffini S; Cicardi M
    Allergy; 2009 Feb; 64(2):254-7. PubMed ID: 19076541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor.
    Malbran A; Hammer CH; Frank MM; Fries LF
    J Allergy Clin Immunol; 1988 Jun; 81(6):1199-204. PubMed ID: 2454251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1-inhibitor deficiency and angioedema.
    Carugati A; Pappalardo E; Zingale LC; Cicardi M
    Mol Immunol; 2001 Aug; 38(2-3):161-73. PubMed ID: 11532278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J; Sim RB; Whaley K; Feighery C
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor.
    Kleiner GI; Giclas P; Stadtmauer G; Cunningham-Rundles C
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):461-4. PubMed ID: 11345293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.
    Wu MA; Castelli R
    Clin Chem Lab Med; 2016 Feb; 54(2):207-14. PubMed ID: 26068904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency.
    Castelli R; Cicardi M; Gardinali M; Zingale LC; Savi C; Munari M; Agostoni A
    Int J Artif Organs; 1997 Mar; 20(3):175-7. PubMed ID: 9151154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune angioedema: a new role for autoantibody in disease pathogenesis.
    Jackson J; Feighery C
    Autoimmunity; 1990; 7(2-3):181-7. PubMed ID: 2104184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody-mediated acquired deficiency of C1 inhibitor.
    Alsenz J; Bork K; Loos M
    N Engl J Med; 1987 May; 316(22):1360-6. PubMed ID: 3494945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune acquired form of angioedema that responded to danazol therapy.
    Higa S; Hirata H; Minami S; Hashimoto S; Suemura M; Saeki Y; Kawase I; Tanaka T
    Intern Med; 2002 May; 41(5):398-402. PubMed ID: 12058892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.
    Alsenz J; Lambris JD; Bork K; Loos M
    J Clin Invest; 1989 Jun; 83(6):1794-9. PubMed ID: 2723058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency).
    Cugno M; Bergamaschini L; Uziel L; Cicardi M; Agostoni A; Jie AF; Kluft C
    J Clin Chem Clin Biochem; 1988 Jul; 26(7):423-7. PubMed ID: 3146615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.